What was the overall market valuation for the Italy covid 19-diagnostics market in 2024?

The overall market valuation was $196.91 Million in 2024. Read More

What is the projected market valuation for the Italy covid 19-diagnostics market by 2035?

The projected market valuation for 2035 is $340.25 Million. Read More

What is the expected CAGR for the Italy covid 19-diagnostics market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 5.1%. Read More

Which companies are considered key players in the Italy covid 19-diagnostics market?

Key players include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, BD, Cepheid, Hologic, and PerkinElmer. Read More

What were the revenue ranges for PCR tests in the Italy covid 19-diagnostics market?

The revenue range for PCR tests was between $60.0 Million and $100.0 Million. Read More

How did the revenue for antigen tests compare to that of antibody tests in 2024?

Antigen tests generated revenue between $50.0 Million and $80.0 Million, while antibody tests ranged from $40.0 Million to $60.0 Million. Read More

What was the revenue range for home care as an end user in the Italy covid 19-diagnostics market?

Home care as an end user had a revenue range of $46.91 Million to $80.25 Million. Read More

Which sample type generated the highest revenue in the Italy covid 19-diagnostics market?

Serum generated the highest revenue, with a range of $76.91 Million to $135.25 Million. Read More

What distribution channel had the highest revenue range in the Italy covid 19-diagnostics market?

Online sales had the highest revenue range, between $76.91 Million and $135.25 Million. Read More

What is the projected growth trend for the Italy covid 19-diagnostics market in the coming years?

The market is expected to grow steadily, reaching $340.25 Million by 2035, indicating a positive growth trend. Read More

Italy COVID 19 Diagnostics Market

ID: MRFR/MED/51440-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Italy COVID-19 Diagnostics Market Research Report By Test Type (PCR Tests, Antigen Tests, Antibody Tests, CRISPR Tests), By End User (Hospitals, Clinics, Laboratories, Home Care), By Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Saliva, Serum) and By Distribution Channel (Direct Sales, Retail Pharmacies, Online Sales) - Growth & Industry Forecast 2025 To 2035

Italy COVID 19 Diagnostics Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Test Type (USD Million)
  1. 4.1.1 PCR Tests
  2. 4.1.2 Antigen Tests
  3. 4.1.3 Antibody Tests
  4. 4.1.4 CRISPR Tests
2. 4.2 Construction, BY End User (USD Million)
  1. 4.2.1 Hospitals
  2. 4.2.2 Clinics
  3. 4.2.3 Laboratories
  4. 4.2.4 Home Care
3. 4.3 Construction, BY Sample Type (USD Million)
  1. 4.3.1 Nasopharyngeal Swabs
  2. 4.3.2 Oropharyngeal Swabs
  3. 4.3.3 Saliva
  4. 4.3.4 Serum
4. 4.4 Construction, BY Distribution Channel (USD Million)
  1. 4.4.1 Direct Sales
  2. 4.4.2 Retail Pharmacies
  3. 4.4.3 Online Sales
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 BD (Becton, Dickinson and Company) (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cepheid (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hologic (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 PerkinElmer (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 ITALY MARKET ANALYSIS BY TEST TYPE
3. 6.3 ITALY MARKET ANALYSIS BY END USER
4. 6.4 ITALY MARKET ANALYSIS BY SAMPLE TYPE
5. 6.5 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY TEST TYPE, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY TEST TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY END USER, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY SAMPLE TYPE, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY END USER, 2025-2035 (USD Million)
  3. 7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Italy Construction Market Segmentation

Construction By Test Type (USD Million, 2025-2035)

PCR Tests
Antigen Tests
Antibody Tests
CRISPR Tests

Construction By End User (USD Million, 2025-2035)

Hospitals
Clinics
Laboratories
Home Care

Construction By Sample Type (USD Million, 2025-2035)

Nasopharyngeal Swabs
Oropharyngeal Swabs
Saliva
Serum

Construction By Distribution Channel (USD Million, 2025-2035)

Direct Sales
Retail Pharmacies
Online Sales

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”